The metabolic effects of intermittent fasting in patients with type 2 diabetes exist in the short term but disappear after its discontinuation: A systematic review and meta-analysis of randomized controlled trials
Nutrition Research · 2025
DOI: 10.1016/j.nutres.2025.04.008 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrition Research, 2025. Verfasst von Fangjun Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Public health School, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Fasting. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
This meta-analysis aimed to determine the short- (< 3 months) and long-term (≥ 3 months) metabolic effects of IF in patients with type 2 diabetes. We hypothesized that IF is non-inferior to other dietary control methods (including continuous energy restriction, standard diet, Mediterranean diet and ad libitum diet) in terms of both short-term and long-term metabolic impacts in patients with type 2 diabetes. We searched for studies in the MEDLINE, EMBASE, and Cochrane Library until August 20, 2023. Studies with non-type 2 diabetes patients, interventions other than IF, no control group, or non-randomized clinical trial designs were excluded. A meta-analysis was then conducted with a random effects model. The Risk of Bias was assessed using the Cochrane risk-of-bias tool (ROB 2). 12 articles with a total of 966 participants were included. IF significantly decreased glycated hemoglobin A1c (HbA1c) (standardized mean difference [SMD]: -0.93; 95% confidence interval [CI]: -1.64, -0.22; P = 0.01), fasting plasma glucose (FPG) (SMD: -0.73; 95% CI: -0.92, -0.54; P < 0.00001) and body weight (SMD: -1.11; 95% CI: -1.92, -0.31; P = 0.007) in the short term compared to control interventions, but showed a similar effect to control interventions in the long term. Substantial heterogeneity existed among our studies. Over the intervention period, long-term IF may safely and feasibly help patients with type 2 diabetes effectively manage blood sugar and reduce body weight, but the metabolic benefits of IF don't endure after its discontinuation. Therefore, continual long-term IF may provide more lasting metabolic benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Public health School, Hebei Medical University, Shijiazhuang, China.
- Public health School, Hebei Medical University, Shijiazhuang, China. Electronic address: 17700864@hebmu.edu.cn.
Zitieren
APA
Liu, F., Zhang, Z., Sun, W., & Li, T. (2025). The metabolic effects of intermittent fasting in patients with type 2 diabetes exist in the short term but disappear after its discontinuation: A systematic review and meta-analysis of randomized controlled trials. Nutrition Research. https://doi.org/10.1016/j.nutres.2025.04.008
Vancouver
Liu F, Zhang Z, Sun W, Li T. The metabolic effects of intermittent fasting in patients with type 2 diabetes exist in the short term but disappear after its discontinuation: A systematic review and meta-analysis of randomized controlled trials. Nutrition Research. 2025. doi:10.1016/j.nutres.2025.04.008
BibTeX
@article{Liu2025,
author = {Liu, Fangjun and Zhang, Zhengxin and Sun, Wenjie and Li, Tao},
title = {The metabolic effects of intermittent fasting in patients with type 2 diabetes exist in the short term but disappear after its discontinuation: A systematic review and meta-analysis of randomized controlled trials},
journal = {Nutrition Research},
year = {2025},
doi = {10.1016/j.nutres.2025.04.008}
}
EUVIMED